Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.

Astrid Friebe; Martin Horn; Folkhart Schmidt; Gesa Janssen; Monika-H Schmid-Wendtner; Matthias Volkenandt; Axel Hauschild; Charlie H Goldsmith; Martin Schaefer

doi:10.1176/appi.psy.51.6.466

Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.

Astrid Friebe^* (Erstautor/-in), Martin Horn, Folkhart Schmidt, Gesa Janssen, Monika-H Schmid-Wendtner, Matthias Volkenandt, Axel Hauschild, Charlie H Goldsmith, Martin Schaefer

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

39 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	466-473
Fachzeitschrift	PSYCHOSOMATICS
Jahrgang	51
Ausgabenummer	6
DOIs	https://doi.org/10.1176/appi.psy.51.6.466
Publikationsstatus	Veröffentlicht - 2010

Zugriff auf Dokument

10.1176/appi.psy.51.6.466

Dieses zitieren

Friebe, A., Horn, M., Schmidt, F., Janssen, G., Schmid-Wendtner, M.-H., Volkenandt, M., Hauschild, A., Goldsmith, C. H., & Schaefer, M. (2010). Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma. PSYCHOSOMATICS , 51(6), 466-473. https://doi.org/10.1176/appi.psy.51.6.466

Friebe, Astrid ; Horn, Martin ; Schmidt, Folkhart et al. / Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma. in: PSYCHOSOMATICS 2010 ; Jahrgang 51, Nr. 6. S. 466-473.

@article{c3f6f4dd273f434a94027fc310262b8e,

title = "Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.",

keywords = "HEPATITIS-C, HIGH-RISK, PEGYLATED INTERFERON-ALPHA-2A, CUTANEOUS MELANOMA, THERAPY, PAROXETINE, CANCER, TRIAL",

author = "Astrid Friebe and Martin Horn and Folkhart Schmidt and Gesa Janssen and Monika-H Schmid-Wendtner and Matthias Volkenandt and Axel Hauschild and Goldsmith, {Charlie H} and Martin Schaefer",

year = "2010",

doi = "10.1176/appi.psy.51.6.466",

language = "English",

volume = "51",

pages = "466--473",

journal = "PSYCHOSOMATICS ",

issn = "0033-3182",

number = "6",

}

Friebe, A, Horn, M, Schmidt, F, Janssen, G, Schmid-Wendtner, M-H, Volkenandt, M, Hauschild, A, Goldsmith, CH & Schaefer, M 2010, 'Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.', PSYCHOSOMATICS , Jg. 51, Nr. 6, S. 466-473. https://doi.org/10.1176/appi.psy.51.6.466

Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma. / Friebe, Astrid (Erstautor/-in); Horn, Martin; Schmidt, Folkhart et al.
in: PSYCHOSOMATICS , Jahrgang 51, Nr. 6, 2010, S. 466-473.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.

AU - Friebe, Astrid

AU - Horn, Martin

AU - Schmidt, Folkhart

AU - Janssen, Gesa

AU - Schmid-Wendtner, Monika-H

AU - Volkenandt, Matthias

AU - Hauschild, Axel

AU - Goldsmith, Charlie H

AU - Schaefer, Martin

PY - 2010

Y1 - 2010

KW - HEPATITIS-C

KW - HIGH-RISK

KW - PEGYLATED INTERFERON-ALPHA-2A

KW - CUTANEOUS MELANOMA

KW - THERAPY

KW - PAROXETINE

KW - CANCER

KW - TRIAL

U2 - 10.1176/appi.psy.51.6.466

DO - 10.1176/appi.psy.51.6.466

M3 - Original Article

C2 - 21051677

SN - 0033-3182

VL - 51

SP - 466

EP - 473

JO - PSYCHOSOMATICS

JF - PSYCHOSOMATICS

IS - 6

ER -

Friebe A, Horn M, Schmidt F, Janssen G, Schmid-Wendtner MH, Volkenandt M et al. Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma. PSYCHOSOMATICS . 2010;51(6):466-473. doi: 10.1176/appi.psy.51.6.466